New Treatment for Breast Cancer
Saturday, November 18th, 2006The news that the world’s first targeted therapy, trastuzumab (Herceptin), is now available for many women with early-stage HER2-positive breast cancer “highlights a truly significant advance in the management of breast cancer,” says Edith Perez, M.D., director of Mayo Clinic’s Breast Clinic in Jacksonville, Fla.Dr. Perez, who led one of the four pivotal studies that [...]
